Developments during 2020 related to Food and Drug Administration (FDA) and Drug Enforcement Administration (DEA) regulatory and enforcement activities — including the FDA’s activities related to the COVID-19 public health emergency — are likely to reverberate throughout 2021.

This white paper from Thompson FDA presents our list of the 10 most important FDA and DEA developments of 2020, and some predictions of what to expect during 2021.